Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies
Crossref DOI link: https://doi.org/10.1007/s40121-022-00598-9
Published Online: 2022-02-20
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paterson, David L.
Kinoshita, Masahiro
Baba, Takamichi
Echols, Roger
Portsmouth, Simon
Funding for this research was provided by:
Shionogi Inc. USA
Text and Data Mining valid from 2022-02-20
Version of Record valid from 2022-02-20
Article History
Received: 8 December 2021
Accepted: 26 January 2022
First Online: 20 February 2022